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Abstract
Background: Using a rat model we have found that the bioflavonoid silymarin (SY) ameliorates
some of the negative consequences of in utero exposure to ethanol (EtOH). In the current study
our aim was to determine if laterality preference and corpus callosum development were altered
in rat offspring whose mothers were provided with a concomitant administration of SY with EtOH
throughout gestation.
Methods: We provided pregnant Fisher/344 rats with liquid diets containing 35% ethanol derived
calories (EDC) throughout the gestational period. A silymarin/phospholipid compound containing
29.8% silybin was co administered with EtOH to a separate experimental group. We tested the
offspring for laterality preference at age 12 weeks. After testing the rats were sacrificed and their
brains perfused for later corpus callosum extraction.
Results: We observed incomplete development of the splenium in the EtOH-only offspring.
Callosal development was complete in all other treatment groups. Rats from the EtOH-only group
displayed a left paw preference; whereas control rats were evenly divided between right and left
paw preference. Inexplicably both SY groups were largely right paw preferring.
Conclusions: The addition of SY to the EtOH liquid diet did confer some ameliorative effects
upon the developing fetal rat brain.
Background
Fetal alcohol syndrome (FAS) children do not display the
normal hemispheric dominance patterns observed in
non-FAS children [1]. Dominance has been disrupted or
is, in some cases, completely absent, depending on the
amount of tissue loss in the corpus callosum. Morpholog-
ical abnormalities, one of which is corpus callosum hypo-
plasia, has been observed in children with FAS [2].
Archibald et al. [3], using structural magnetic imaging
(sMRI), also noted that there were corpus callosum abnor-
malities in children who had experienced prenatal expo-
sure to ethanol. In a magnetic resonance imaging (MRI)
study of adult FAS males, callosal morphological data,
when compared with landmark data, differed significantly
from that of control males [4].
Agenesis of the corpus callosum occurs as a consequence
of early embryonic insult. The exact time of the insult usu-
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ally determines the extent of commissural agenesis. Jeeves
et al. [5] reported a timetable in which, if the insult occurs
before the tenth embryonic week (in humans), all fore-
brain commissures will be absent. Miller [6] observed that
in utero exposure to ethanol (EtOH) disrupted the distri-
bution of callosal projection neurons in the rat somato-
sensory cortex. The complete absence of a corpus
callosum in rats exposed in utero to EtOH has been docu-
mented by several studies [7–9]. Because in utero expo-
sure to EtOH affects both corpus callosum development
and laterality, researchers have turned to the rat model to
assess the impact of EtOH on both measures.
In Zimmerberg et al. [10] rats prenatally exposed to a 35%
ethanol derived calories (EDC) liquid diet did not display
a preferred side for the 2-hole nose-poke apparatus, un-
like rats whose mothers were maintained on a chow or
liquid diet. Later, Zimmerberg et al. [1] assessed laterality
using a left/right lever choice on a continuous reinforce-
ment schedule. Again the rats exposed in utero to EtOH
displayed less side preference than the chow fed and liq-
uid diet pairfed rats. When London [11] tested paw pref-
erence in rats, he found that rats exposed to ethanol
during gestation were more likely than control rats to pref-
erentially use the left paw. In 1989, Zimmerberg et al. [12]
tested preferred tail direction in neonates exposed in utero
to EtOH. When compared to the 0% EDC group and the
chow group, a left-preferred tail direction was exhibited
by rats from the 35% EDC group. Thus it appears that in
utero exposure to ethanol, at least in rats, results in a dis-
ruption of laterality patterns.
We have investigated the potential fetoprotective capacity
of silymarin (SY) against the toxic effects of in utero expo-
sure to ethanol. Silymarin has long been noted for its
hepatoprotective properties [13]. The mechanisms
through which SY is thought to manifest its therapeutic ef-
fects include the following: 1) enhanced protein synthesis
[14], 2) scavenging free radicals [15], 3) prevention of glu-
tathione (GSH) depletion [16], and 4) preservation of cell
membrane integrity [17]. The theories formulated to ex-
plain the physiological events that culminate in fetal alco-
hol syndrome include decreased antioxidant levels,
decreased protein synthesis, increased free radical activity,
and disrupted membrane function. The observation that
the protective effects of SY and the causal factors in FAS
overlap, led us to investigate the possibility that SY might
have application as a fetoprotectant compound. In a series
of studies conducted in our lab we have demonstrated
that the coadministration of SY with ethanol prevents eth-
anol-induced decreases in neonate mortality rate, decreas-
es in pup birth weight, and increases in liver and brain
gamma glutamyl transpeptidase (GGTP) activity [18,19].
SY also prevented the deficits in spatial memory and so-
cial memory observed in rats exposed in utero to EtOH
[20,21].
Given that SY has been successful in ameliorating some of
the negative consequences of in utero exposure to EtOH
(in the rat model), we examined the possibility that SY
might prevent EtOH-induced callosal agenesis and the
disruption of laterality (as measured by paw preference).
Methods
Subjects
Subjects were 50 female Fisher/344 rats weighing 235–
245 g. The females were housed with male rats until preg-
nancy was confirmed by vaginal smear. Once pregnancy
was confirmed, the rats were placed in standard plastic
laboratory maternal tubs and assigned to one of five ges-
tational treatment groups. Ten pregnant females were as-
signed to each treatment group. Group 1 consisted of
pregnant females that received the liquid diet regimen (Bi-
oserve; Frenchtown, NJ) containing an isocaloric amount
of dextrin maltose that matched the caloric amount in the
EtOH diet. Group 2 rats were provided with the liquid diet
to which a 400-mg/kg dose of silymarin (SY) was added.
The SY, provided by Inverni della Beffa, Milano, Italy, con-
tained 29.8% silybin complexed with phosphatidylcho-
line. The dose administered to the rats was based on the
percent active ingredient in the compound and was de-
rived from data acquired in our previous studies [18,19].
Group 3 rats received the liquid diet, which contained
both the SY and 35% ethanol-derived calories (6.7%
EtOH solution). In previous studies we established blood
alcohol concentrations (BACs) for all experimental
groups and ascertained that SY does not have any appreci-
able affect on BAC [21]. The rats in Group 4 were main-
tained on the 35% EDC liquid diet and Group 5 rats were
provided with unlimited access to Purina lab chow. The
amount of liquid diet provided to the rats in Groups 1, 2,
and 3 was determined by the amount of liquid diet con-
sumed the preceding day by the rats in Group 4. The liq-
uid diet treatments were discontinued five days before the
dams gave birth at which time they were provided access
to Purina lab chow. When the EtOH administration is
continued until birth, pup survival rats are extremely low.
Once pups reached age 18–21 days they were weaned and
placed in individual standard laboratory cages. On the
day of weaning we randomly selected one female pup
from each litter and as subjects in the laterality testing pro-
cedure. We used females in an effort to remedy the paucity
of FAS-related data collected on female rodents. A total of
10 female rat pups were selected from each of the five orig-
inal treatment groups.BMC Complementary and Alternative Medicine 2002, 2 http://www.biomedcentral.com/1472-6882/2/10
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Apparatus and procedures
Testing apparatus for laterality
All testing sessions took place in a reaching apparatus. The
apparatus was made up of three contiguous plastic cubi-
cles, each of which measured 24.13 cm × 7.62 cm × 16.41
cm. The adjoining walls of the cubicle were 6.35 mm thick
and were painted white so that rats in adjacent cubicles
could not see each other. An 11 mm tube was installed in
the face of each cubicle. All test sessions were videotaped.
Laterality testing procedure
The rats began laterality testing at age 12 weeks. They were
food-deprived for 14–21 hr prior to the testing sessions
and each rat participated in three testing sessions. They
were placed three at a time into the reaching apparatus,
one in each cubicle. Rats remained in the reaching appa-
ratus until they had either reached 50 times for food (Fruit
Loops) or one hour had passed. A single Fruit Loop was
placed in the reaching tube for each trial. A successful
reach was defined as the rat obtaining the piece of Fruit
Loop. Each time the Fruit Loop was retrieved another
piece was immediately placed into the tube. Upon com-
pletion of a testing session rats were taken out of the
reaching apparatus and placed back into their cage.
Perfusion
After all of the rats had completed the reaching protocol
they were anesthetized and intracardially injected first
with Ringers solution and then with a fixing solution. Af-
ter sacrifice the brains were removed, preserved in forma-
lin, and stored in a refrigerator for later corpus callosum
extraction.
Corpus callosum extraction
Because hemisphere weights were also dependent varia-
bles a cut was made through the longitudinal fissure that
separated the two hemispheres, which then exposed the
two halves of the corpus callosum. The hemispheres were
weighed separately prior to corpus callosum extraction.
Using a surgical knife the corpus callosum was outlined
and lifted away from the rest of the brain. The two halves
of the corpus callosum were weighed separately on an an-
alytical balance. The total length of the corpus callosum
was measured before and after extraction. The genu, body,
and splenium were identified to confirm complete devel-
opment of the corpus callosum.
Statistics
The criterion for assessing individual laterality was gener-
ated from binomial z scores. To identify a group of rats as
demonstrating paw preference, 7 of 10 rats had to be ob-
served reaching in the same direction. Three raters, who
were unaware of treatment groupings, observed and
counted the reaches. The Statistical Package for Social Sci-
ences (SPSS) Reliability Analysis was used for inter-rater
reliability. A priori contrasts were conducted to determine
if differences existed between groups on all dependent
measures (laterality, corpus callosum [development and
weight], splenium development, total brain weight, and
pup weight gain).
Results
Pup weights were recorded at birth and again when the
rats were weaned. An ANOVA and subsequent post hoc
Tukey comparisons revealed that there were no significant
birth weight differences for any experimental group as
compared with the LD group; although, the overall ANO-
VA was significant, F(4, 45) = 4.98, p < .05). However,
when the wean weights were analyzed, the ANOVA results
were significant, F(4, 45) = 6.77, p < .01 and, the posthoc
tests specified that the EtOH group (M = 43.12 g) differed
significantly from the LD group (M = 50.08 g), t(45) =
4.476, p < .001. This indicates that the EtOH pups gained
comparatively less weight during the period between post-
natal day (PND) 1 and PND 20, which is when the pups
were weaned. A percent weight gain was calculated for
Table 1: Weight at Birth and Weaning and Percent Weight Gain
Birth Weight (g) Wean Weight (g) % Weight Gain
MS D MS D
LD 5.65 .326 50.08 9.11 89
EtOH 4.96* .721 34.12*** 5.18 85
SY/EtOH 5.66 .730 47.39 8.09 88
SY 5.94 .512 42.66* 6.54 86
Chow 6.03 .598 49.18 9.99 87
Note. * = <.05; ** = < .01; *** = <.001. All comparisons were made to the LD group. N = 10 for each group.BMC Complementary and Alternative Medicine 2002, 2 http://www.biomedcentral.com/1472-6882/2/10
Page 4 of 6
(page number not for citation purposes)
each group (see Table 1). Eta square was calculated and in-
dicated that 61% of the variance in pup weight gain values
was attributable to the treatment received during gesta-
tion.
Total brain weight and corpus callosum weight were de-
termined for each of the pups and a total weight to corpus
callosum ratio calculated (see Table 2). Eta square was
again calculated for the variance in corpus callosum
weight resulting in 56% of the variance attributable to the
treatment condition. After perfusion the brains were visu-
ally inspected to determine whether or not the splenium
was fully developed. Of the 50 rats tested, 8 did not have
a fully developed splenium. All 8 rats were from the EtOH
group (see Table 3). A priori contrasts were conducted to
assess group differences. All of the group comparisons
were made with the Liquid Diet (LD) group. Significant
differences are reported in Tables 1,2,3.
Discussion
EtOH had an adverse impact on birth weight as indicated
in Table 1. Further, the in utero exposure to EtOH also
prevented normal weight gain during the 20-day suckling
period. SY given in combination with EtOH appeared to
prevent the EtOH-associated low birth weight and attenu-
ated weight gain. Although the birth weight of the SY-only
pups was normal, weight gain during the suckling period
was significantly less than that of the LD group. Weight
gain for the SY pups, however, was still more than that ob-
served for the EtOH pups. In a previous study [20] SY pup
weight gain did not differ significantly from weight gained
by LD pups.
Brain weights did not differ significantly, although the
lowest weights were observed in the EtOH. Corpus callo-
sum (CC) weights did vary significantly, for which the
EtOH pups had the lowest weights. Inexplicably, the
Chow pup callosal data weight data did not differ from
that of the EtOH pups. However, when the ratio of brain
weight to CC weight was calculated there were no signifi-
cant group differences. The EtOH group brain to CC
weight ratio indicated that the CC weight as compared to
total brain weight was the lowest observed among all of
the treatment groups. This lower CC weight might be as-
sociated with the unusual left paw preference displayed by
the EtOH pups. As an indication of EtOH and SY fetal ef-
fects the CC weight measure does not seem to provide
much relevant information, whereas the measure of sple-
nium development clearly indicates EtOH-induced dis-
ruption. The in utero effect of EtOH on splenium
development has also been observed in humans with FAS.
Sowell et al. [22], using MRI analytic methods determined
that EtOH-related callosal area reductions were most se-
vere in the splenium.
Consistent with the London [11] investigation, the EtOH-
exposed rats displayed a left paw preference. Further evi-
dence of laterality disruption was manifested by incom-
plete splenium development in 8 of the 10 EtOH-exposed
rats. The paw preference scores in the LD and Chow
groups indicated an even distribution between left and
right paw preference. An unexpected finding was that of
the strong right paw preference displayed by the rats from
the SY and SY/EtOH groups. Given the 50:50 left/right
paw preference of the Chow and LD groups; the expected
outcome of SY influence would be the preservation of the
50:50 ratio. The SY paw preference results are, however,
consistent with a very recent study by Pence [23]. Male
and female rats were tested for paw preference using a
food-reaching task. There was no significant sex differ-
ence. He did observe that 70.2% of the rats were right
pawed, 19.3% were left pawed, and 11.9% were ambidex-
trous. Our observations can be summarized as follows: 1)
Fisher/344 rats when not subject to any form of prenatal
insult and subsequently raised with adequate nutrition
and housing do not, as a group, display any particular paw
Table 2: Weight of Brain and Corpus Callosum and Brain:CC Ratio
Brain Weight (g) CC Weight (g) Ratio Brain:CC
MS D MS D
LD 1.937 .066 .001409 .0015 1:137
EtOH 1.304 .135 .000802*** .0005 1:162
SY/EtOH 1.945 .117 .001267** .0012 1:152
SY 1.899 .182 .001277* .0015 1:148
Chow 1.378 .043 .000985*** .0009 1:139
Note. * = <.05; ** = < .01; *** = <.001. All comparisons were made to the LD group. N = 10 for each group.BMC Complementary and Alternative Medicine 2002, 2 http://www.biomedcentral.com/1472-6882/2/10
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preference. 2) Rats when exposed in utero to EtOH expe-
rience tissue loss in the splenium and, as a group, display
a left paw preference. 3) Rats that have been exposed in
utero to EtOH co-administered with SY have a fully intact
corpus callosum, yet display a right-paw preference. Why
SY would have any impact on laterality that is distinct
from EtOH exposure is puzzling. There is a possible expla-
nation in light of the gender-specific differences observed
in callosal size [24] coupled with the fact that prenatal ex-
posure to EtOH causes feminization of male rats and de-
feminization of female rats [12,25,26]. There is a
hormonal influence on the developing commissural path-
way that could be disrupted by a number of EtOH-in-
duced aberrations in hormone activity, such as the
diminished perinatal surge of testosterone observed in
EtOH-exposed male fetal rats [27]. The EtOH-induced at-
tenuation of the testosterone surge eliminated the normal
sex difference in rat callosal size. In a previous study we
observed that the coadministration of SY with EtOH to
pregnant dams prevented the EtOH-induced deficits in so-
cial recognition observed in the EtOH-exposed offspring
[20]. Social memory in rats is a sexually dimorphic behav-
ior that requires adequate levels of perinatal and neonatal
androgen activity. In utero exposure to EtOH reduces tes-
tosterone levels as well as maternal levels of estrogen; con-
sequently there is a reduction in P450-aromatase activity
[28,29]. This then results in a reduction in estrogen and
estrogen receptor activation. Estrogen receptor activity is
necessary for the expression of androgen-driven behavior
in rodents [30,27]. In addition to behavior, estrogen also
affects neurogenesis, synaptogenesis, and synaptic modi-
fications [31]. Our subjects were the female offspring of
the various treatment groups. As previously confirmed
[32], the rat's corpus callosum (CC) is a sexually dimor-
phic structure with the larger CC observed in male rats.
Fitch and colleagues [32] also determined that the femini-
zation (reduction in size as compared to the CC of male
rats) of the female CC only occurs if the ovaries are intact
and the CC is exposed to estrogen. Recently, Bimonte et al.
[33] established that neonatal exposure to estrogen is es-
sential to feminine-specific brain organization to the ex-
tent that the brain can respond appropriately to the
organizing effects of subsequent estrogen exposure. Exper-
imental rats were administered an estrogen receptor
blocker, and later at postnatal day 70 these rats responded
to estrogen administration with an increase in CC size; an
effect opposite of what would be expected. Dehmlow et
al. [17] have established that silymarin can compete with
estradiol at estradiol receptor binding sites [17]. There-
fore, it is possible that the ameliorative effects of SY ob-
served in the present study can be attributed to estrogen
receptor activation at developmentally appropriate times.
Conclusions
Because callosal development was complete in rats ex-
posed to the co-administration of SY with EtOH, it ap-
pears that SY conferred some ameliorative effects upon
the corpus callosum developmental process. Without the
SY, EtOH-exposed pups clearly displayed EtOH-induced
disruption to normal callosal development. Even though
the mechanism for the protective action of SY is not clear-
ly understood, our consistent findings of fetoprotectivity
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